DLD Asset Management »

Gilead Sciences shares owned by DLD Asset Management

Quarter-by-quarter ownership of Gilead Sciences (GILD) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Gilead Sciences

Tip: Access up to 7 years of quarterly data

All positions including Gilead Sciences held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gilead Sciences by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $253k 2.0k 126.34
2025-06-30 $3.5M 32k 110.87

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Akamai Technologies Note 0.250% 5/1 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Marathon Digital Holdings In Put Option (MARA)
Eli Lilly & Co. Call Option (LLY)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Encore Cap Group Note 4.000% 3/1 (Principal)
Patrick Inds Note 1.750%12/0 (Principal)
Super Micro Computer Com New Put Option (SMCI)
Merit Med Sys Note 3.000% 2/0 (Principal)

View all positions for DLD Asset Management

Top funds holding Gilead Sciences

BlackRock
Vanguard Capital Management
FMR
State Street Corporation
Capital World Investors
Invesco
Vanguard Portfolio Management
Geode Capital Management
T. Rowe Price Associates
Dodge & Cox
Morgan Stanley
Norges Bank Investment Management
Jpmorgan Chase & Co
Capital Research Global Investors
Bank of America Corporation

View all funds holding Gilead Sciences